The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
Bleeding Disorders Market contains market size and forecasts of Bleeding Disorders in Global, including the following market information:
- Global Bleeding Disorders Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bleeding Disorders market was valued at 11130 million in 2021 and is projected to reach US$ 16870 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Plasma-derived Coagulation Factor Concentrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bleeding Disorders include Novo Nordisk, Bayer, Baxter International, Alnylam Pharmaceuticals, Pfizer, Xenetic Biosciences, Bristol-Myers Squibb Company, Sanofi and Janssen Global Services, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bleeding Disorders companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bleeding Disorders Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bleeding Disorders Market Segment Percentages, by Type, 2021 (%)
- Plasma-derived Coagulation Factor Concentrates
- Recombinant Coagulation Factor Concentrates
- Desmopressin
- Antifibrinolytics
- Fibrin Sealants
- Others
Global Bleeding Disorders Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bleeding Disorders Market Segment Percentages, by Application, 2021 (%)
- Hemophilia A
- Hemophilia B
- Others
Global Bleeding Disorders Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bleeding Disorders Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Bleeding Disorders revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Bleeding Disorders revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Bayer
- Baxter International
- Alnylam Pharmaceuticals
- Pfizer
- Xenetic Biosciences
- Bristol-Myers Squibb Company
- Sanofi
- Janssen Global Services
- Bioverativ
- Amgen
Industry Market Size
